Eloquest Healthcare News and Events
Eloquest Healthcare Joins APIC to Support International Infection Prevention Week
Eloquest Healthcare is proud to sponsor the Association for Professionals in Infection Control and Epidemiology public service campaign, International Infection Prevention Week, which aims to raise awareness about the importance of infection prevention and the essential role infection preventionists (IPs) play in public health and will take place October 16-22. Read More.
New study adds to evidence on best CVAD securement methodology
A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in place, compared to either suture-based or adhesive device-based securement methods. Read More.
New research from Dignity Health on improving quality of life for LVAD patients
A study at Dignity Health Mercy General Hospital showed that use of a special liquid adhesive to increase the durability of driveline (DL) dressings can reduce the risk of infection and improve quality of life for heart failure patients with left ventricular assist devices (LVADs). Read more.
Eloquest Healthcare and Interrad Medical Partner to Expand U.S. Sales of SecurAcath
The partnership adds the revolutionary SecurAcath device to Eloquest Healthcare’s existing clinically oriented product offering. Read more.
Access Vascular Inc. (AVI) and Eloquest Healthcare Partner to Improve Vascular Access Outcomes
The partnership combines Eloquest’s existing clinically oriented product offering and commerical resources with AVI’s transformational device technology.
Eloquest Healthcare partners with Adventist Health Global Missions to support their efforts of providing care and performing surgeries in remote communities abroad
In 2019 and again in September of 2020, Eloquest Healthcare partnered with Adventist Health Global Missions to support their efforts of providing care and performing surgeries in remote communities abroad without access to these services.
Eloquest Healthcare is excited to announce new, 5-year MedSurg agreement with group purchasing organization Vizient Supply, LLC that will include Mastisol® Liquid Adhesive, Detachol® Adhesive Remover and ReliaTect® Post-Op Dressing with CHG. Under the new agreement, Vizient members can take advantage of special pricing for these products.
Eloquest Healthcare, Inc. is honored to announce today announced that it is Great Place to Work-Certified™ for 2019-2020!
Eloquest Healthcare, Inc. is honored to announce that Fortune and Great Place to Work have recognized us as one of the 2018 Best Workplaces in Health Care & Biopharma!